Paperpal Prime Logo

AIDS Research and Therapy : Impact Factor & More

eISSN: 1742-6405pISSN: 1742-6405
JournalOpen Access

Key Metrics

CiteScore
2.5
Impact Factor
< 5
SJR
Q3Virology
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on AIDS Research and Therapy

AIDS Research and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2290 | USD 2790 | GBP 1890
Publication Time16
Editorial Review ProcessPeer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in AIDS Research and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in AIDS Research and Therapy

From inflammatory to reconstitution: a longitudinal exploratory study of cytokine dynamics in HIV/TB co-infected patients.
  • 20 Jul 2026
  • AIDS research and therapy
Burden and determinants of hyperuricemia among adults living with HIV at Lira Regional Referral Hospital in Uganda : a cross-sectional study.
  • 18 Jul 2026
  • AIDS research and therapy
Pretreatment HIV-1 drug resistance and molecular subtype characteristics among newly diagnosed individuals in Guangxi, China.
  • 17 Jul 2026
  • AIDS research and therapy
Shifting neuropsychiatric diagnoses across the antiretroviral therapy era at an urban Ugandan HIV centre: a descriptive analysis of routinely collected electronic health records, 2017 to April 2026.
  • 17 Jul 2026
  • AIDS research and therapy
B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.
  • 16 Jul 2026
  • AIDS research and therapy
Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV (PWH) in routine clinical practice in Türkiye: 12-month outcomes from the KLIMIK HIV-TR cohort.
  • 15 Jul 2026
  • AIDS research and therapy
From inflammatory to reconstitution: a longitudinal exploratory study of cytokine dynamics in HIV/TB co-infected patients.
  • 20 Jul 2026
  • AIDS research and therapy
Burden and determinants of hyperuricemia among adults living with HIV at Lira Regional Referral Hospital in Uganda : a cross-sectional study.
  • 18 Jul 2026
  • AIDS research and therapy
Pretreatment HIV-1 drug resistance and molecular subtype characteristics among newly diagnosed individuals in Guangxi, China.
  • 17 Jul 2026
  • AIDS research and therapy
Shifting neuropsychiatric diagnoses across the antiretroviral therapy era at an urban Ugandan HIV centre: a descriptive analysis of routinely collected electronic health records, 2017 to April 2026.
  • 17 Jul 2026
  • AIDS research and therapy
B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.
  • 16 Jul 2026
  • AIDS research and therapy
Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV (PWH) in routine clinical practice in Türkiye: 12-month outcomes from the KLIMIK HIV-TR cohort.
  • 15 Jul 2026
  • AIDS research and therapy

FAQs on AIDS Research and Therapy